IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Celldex Therapeutics Inc

CUSIP: 99D2DH6V9 | 1 institutional holders

Quarters

Q1 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile